These results confirmed that semaglutide benefits heart health beyond just diabetes treatment
Patient Assessment Protocol Comprehensive medical history with obesity-specific screening Physical examination including BMI, waist circumference, and body composition analysis Laboratory workup: complete metabolic panel, lipid panel, HbA1c, thyroid function, insulin levels Screening for sleep apnea, PCOS, Cushing syndrome, and other secondary causes of obesity Mental health screening for binge eating disorder and depression Readiness-to-change assessment Medication Formulary for Your Medical Weight Loss Program GLP-1 receptor agonists: Semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound) Sympathomimetic agents: Phentermine (short-term), phentermine/topiramate (Qsymia) Other FDA-approved options: Naltrexone/bupropion (Contrave), orlistat (Xenical/Alli) Off-label considerations: Metformin, topiramate, bupropion (when clinically appropriate and properly documented) Your medical weight loss program's protocols should specify prescribing criteria, dosing escalation schedules, monitoring requirements, and discontinuation criteria for each medication
Commenters stated that as currently written, the rule could significantly reduce payments for services performed in Ambulatory Surgery Centers (ASCs), most of which are owned and operated by independent physicians and often function as extensions of physicians' offices
Dysaesthesia rates were notably higher with Wegovy 7.2mg injections
Hacham Y, Koussevitzky S, Kirma M, Amir R
If your vial arrived already reconstituted or without a nitrogen/argon seal, contact the vendor before using it
